The Pharma Data

NOVEMBER 13, 2020

We must collectively work to support countries and engage communities to reach everyone, everywhere with measles vaccine and stop this deadly virus.” © 2020 HealthDay. Posted: November 2020. . “These data send a clear message that we are failing to protect children from measles in every region of the world.

Vaccine 52

Vaccine Virus Disease Trials 52

The Pharma Data

NOVEMBER 18, 2020

HIV drug resistance is caused by changes in the genetic structure of HIV that affects the ability of drugs to block the replication of the virus. Between 2004 and 2020, 57 countries implemented surveys of HIV drug resistance using WHO-recommended methods (see map below), and 17 countries have plans to conduct surveys. among adults and.

Laboratories 52

Laboratories Therapies Virus Government 52

The Pharma Data

DECEMBER 2, 2020

It’s not known if these infections were in people who caught the virus in other countries, or whether the infections led to wider community transmission, said the authors of the study that has been accepted for publication in the journal Clinical Infectious Diseases. © 2020 HealthDay. Posted: December 2020.

Virus 52

Virus Disease Research 52

The Pharma Data

AUGUST 22, 2020

He said it was unlikely there would be a vaccine in 2020 but there was a “reasonable chance” of a working jab being ready for the following winter in 2021-22. But this rare interview reveals a lot more about his own views on how the virus is developing. Will children spread the virus to grandparents?

Virus 69

Virus Government Vaccine 69

The Pharma Data

AUGUST 3, 2021

The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2, the virus that causes COVID-19, in human cell cultures and in a mouse model, leading to much lower viral loads. The research team, including scientists from the U.S.

Virus 52

Virus Clinical Trials Drugs Laboratories 52

The Pharma Data

DECEMBER 21, 2020

The team at the Walter Reed Army Institute of Research is checking genetic sequences of the mutated virus variant posted online by British researchers, CNN reported. © 2020 HealthDay. Posted: December 2020. The new coronavirus variant in the UK that appears to spread faster is being studied by U.S. All rights reserved.

Packaging 52

Packaging Vaccine Laboratories Virus 52

SCIENMAG: Medicine & Health

JANUARY 16, 2024

In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious and pathogenic virus, made its alarming debut and quickly spread worldwide, causing the novel coronavirus (COVID-19) pandemic that threatened human health and public safety.

Virus 93

Virus Hospitals 93

The Pharma Data

JANUARY 11, 2021

Food and Drug Administration said the test from California company Curative could produce false negatives, leading people with the virus to unknowingly spread it, the Associated Press reported. Last week, the U.S. The test is used by at least three of the largest U.S. cities, the AP reported.

Virus 52

Virus Vaccine FDA Research 52

The Pharma Data

DECEMBER 31, 2020

Monthly News Roundup – December 2020. The messenger RNA (mRNA) vaccines encode a form of the spike (S) protein of SARS-CoV-2 virus. The vaccine teaches the cells to make a piece of the spike protein, which triggers an immune response to help prevent illness if later exposed to the virus. Posted: December 2020.

FDA Approval 52

FDA Approval Vaccine FDA Treatment 52

The Pharma Data

NOVEMBER 3, 2020

” Prime Minister Boris Johnson also had the virus in the spring. © 2020 HealthDay. Posted: November 2020. At the time, the prince’s office said in a statement that Charles was showing “mild symptoms, but otherwise remains in good health and has been working from home throughout the last few days as usual.”

Hospitals 52

Hospitals Laboratories Doctors Virus 52

The Pharma Data

MARCH 3, 2022

If approved by the FDA, this maternal immunization has the potential to be the first vaccine candidate to help protect infants in their vulnerable first months of life from disease caused by this highly-contagious virus. Burden of RSV RSV is a contagious virus and a common cause of respiratory illness. Pfizer Inc.

Virus 52

Virus Vaccine Clinical Trials Trials 52

Codon

AUGUST 26, 2024

When COVID-19 emerged in 2019, by contrast, mRNA vaccines developed by Pfizer and Moderna took just 326 days from the initial sequencing of the virus to gaining approval for emergency use. These drugs would be ideal tools to bridge the wait for a vaccine against a quickly-spreading virus.

RNA 84

RNA Virus DNA Vaccine 84

Broad Institute

APRIL 25, 2024

A new model Formally launched in early 2020, Sentinel is a new model of pathogen surveillance that its leaders say could be used anywhere in the world. The Sentinel team put an early version of their system to the test in 2020 to respond to COVID-19 and again in 2022 for Mpox surveillance and response efforts.

Virus 132

Virus Hospitals Disease Government 132

The Pharma Data

DECEMBER 30, 2020

The year 2020 will certainly go down in history as the year of COVID-19. Gilead Sciences Makes Multiple Bets : When Gilead Sciences wasn’t working on remdesivir in COVID-19, the company seemed to be constantly flexing its M&A muscle over the course of 2020. It began in May with the $4.9

Science 52

Science Disease Pharmaceuticals Treatment 52

The Pharma Data

APRIL 25, 2021

Nirsevimab demonstrate d protect ion against respiratory syncytial virus disease in healthy infants in Phase 3 trial. Respiratory Syncytial Virus (RSV) is the leading cause of hospitalization in all infants. 1 – 5. RSV is the most common cause of LRTI and the leading cause of hospitalizations in all infants.

Virus 40

Virus Trials Disease Hospitals 40

PLOS: DNA Science

MAY 16, 2024

A Novel Virus Appears In retrospect, everything unfolded with astonishing speed. A few days after New Years, 2020, I heard BBC News report the first cases, in China. Whenever and wherever the virus emerged, CDC officially alerted clinicians to the new, deadly respiratory illness on January 8, 2020.

Virus 98

Virus DNA RNA Science 98

The Pharma Data

OCTOBER 26, 2020

27, 2020 /PRNewswire/ — Aridis Pharmaceuticals, Inc. Dr. Hasan Jafri , Chief Medical Officer of Aridis Pharmaceuticals, will be a speaker on a panel entitled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus.” SAN JOSE, Calif. , AR-711 (COVID-19). AR-201 (RSV infection). AR-201 (RSV infection).

Pharmaceuticals 52

Pharmaceuticals Virus Hospitals Clinical Trials 52

The Pharma Data

NOVEMBER 13, 2020

A new survey shows one in five cancer patients are far less likely to participate in future clinical trials due to fear of COVID-19 exposure, raising the question of whether enrollment levels that have dropped precipitously since the beginning of the pandemic are likely to recover after the virus is controlled. percent since March 15.

Trials 52

Trials Clinical Trials Virus Research 52

The Pharma Data

NOVEMBER 5, 2020

5, 2020 /PRNewswire/ — Third quarter 2020 revenues increased 32% to $2.29 Third quarter 2020 EYLEA ® U.S. Third quarter 2020 Dupixent ® global net sales (2) , which are recorded by Sanofi, increased 69% to $1.07 Third quarter 2020 Dupixent ® global net sales (2) , which are recorded by Sanofi, increased 69% to $1.07

Production 52

Production FDA Trials FDA Approval 52

The Pharma Data

OCTOBER 29, 2020

29, 2020– Alexion Pharmaceuticals, Inc. NASDAQ:ALXN) today announced financial results for the third quarter of 2020. Non-GAAP diluted EPS for the third quarter of 2020 was $3.24 , a 16 percent increase versus the third quarter of 2019. ” Third Quarter 2020 Financial Highlights. in the prior year.

Clinical Trials 40

Clinical Trials Trials Production Licensing 40

Drug Target Review

OCTOBER 26, 2023

1 Adeno-associated virus (AAV) vectors are the leading platform for in vivo gene delivery for the treatment of various human diseases. It has been well established that exposure to wild-type AAV results in priming of the immune system against the virus. Nature 578 , 229-236 (2020). Nature Reviews Genetics 21 , 255-272 (2020).

Engineering 105

Engineering Virus Therapies Immune Response 105

NIH Director's Blog: Drug Development

MARCH 18, 2021

With support from a 2020 NIH Director’s Pioneer Award, Veesler will study members of the order Chiroptera. These days, the Veesler lab has been hard at work to understand SARS-CoV-2 and the human immune response to the virus. 2020 Apr 16;181(2):281-292.e6. Or, more colloquially, bats. Veesler says bats are remarkable creatures.

Virus 52

Virus Immune Response Clinical Trials Treatment 52

The Pharma Data

DECEMBER 20, 2020

BT-001 is a best-in-class oncolytic Vaccinia virus. platform and its patented large-capacity VV cop TK-RR- oncolytic virus, which has been engineered to encode both a Treg-depleting human recombinant anti-CTLA4 antibody generated by BioInvent’s proprietary n-CoDeR ® /F.I.R.S.T LUND, Sweden and STRASBOURG, France , Dec.

Virus 52

Virus Trials Clinical Trials Clinical Development 52

The Pharma Data

OCTOBER 21, 2020

22, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. The offering is expected to close on October 26, 2020, subject to the satisfaction of customary closing conditions. BOSTON, Oct. Morgan Securities LLC, SVB Leerink LLC and Barclays Capital Inc. are acting as joint book-running managers for the offering.

Immune Response 40

Immune Response Clinical Trials Therapies Production 40

The Pharma Data

JANUARY 18, 2021

This announcement follows the approval received in December 2020 from the Belgian health authorities. This announcement follows the approval received in December 2020 from the Belgian health authorities. BT-001 IS AN ONCOLYTIC VIRUS GENERATED WITH TRANSGENE’S INNOVATIVE INVIR.IO BT-001 is based on the patented Invir.IO

Virus 40

Virus Trials Clinical Trials Engineering 40

The Pharma Data

NOVEMBER 10, 2020

S is derived from a common cold virus that is modified to carry a gene from the SARS-CoV-2 virus which causes COVID-19, prompting the immune system to develop resistance to the virus.

Vaccine 40

Vaccine Trials Clinical Trials Virus 40

Drug Target Review

AUGUST 11, 2023

In a new development, a recent paper published in Biology Methods & Protocols by Oxford University Press has highlighted a promising avenue for enhancing vaccine efficacy against infectious pathogens like the COVID-19 virus. The role of extracellular vesicles in COVID-19 virus infection [Internet]. Available from: [link]

Vaccine 98

Vaccine Immune Response Bioinformatics Virus 98

The Pharma Data

NOVEMBER 6, 2020

6, 2020 — As the daily U.S. universities reopened their campuses to students in some capacity this fall, the newspaper said, and some schools have appeared to keep the virus in check, primarily through extensive testing programs. © 2020 HealthDay. Posted: November 2020. FRIDAY, Nov. More than a third of U.S.

Virus 40

Virus Vaccine Government Doctors 40

The Pharma Data

MAY 15, 2023

CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV) Gilead Sciences, Inc. Bulevirtide was initially granted conditional marketing authorisation in July 2020 to provide people living with HDV urgent access to treatment.

Virus 40

Virus Marketing Treatment Science 40

The Pharma Data

DECEMBER 10, 2020

We know now that the viral RNA is found in stool and infectious virus as well. Therefore, Carlson said, “we advised no use of fecal donations from after Dec. 1, 2019, until effective screening methods are implemented.”. There were no methods for testing for COVID in stool,” he said. “We Infection in the GI tract is likely.”

FDA 52

FDA Laboratories RNA Virus 52

PLOS: DNA Science

JUNE 13, 2024

The virus SARS-CoV-2 emerged in Wuhan, home of a premiere research institute that focuses on viruses. An altered virus could have escaped. Evidence that the virus emerged, or escaped, from the wildlife trade is lacking. Her points: 1. Coincidence? I’ve never thought so. RaTG13 shares about 96.1%

Virus 52

Virus RNA DNA Science 52

The Pharma Data

DECEMBER 9, 2020

10, 2020 04:32 UTC. The offering is expected to close on or about December 14, 2020, subject to satisfaction of customary closing conditions. Rocket’s first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon disease, a devastating, pediatric heart failure condition. Forward-looking Statements.

Pharmaceuticals 40

Pharmaceuticals Clinical Trials Therapies Trials 40

New Drug Approvals

DECEMBER 26, 2022

1 heavy chain (1-456) (human vh (homo sapiens ighv1-69*01(ighd)-ighj4*01 (90.1%)) (8.8.19) (1-126) -homo sapiens ighg1*03 Immunoglobulin g1, anti-(human respiratory syncytial virus fusion protein)(human monoclonal med18897.gamma.1-chain), 2020) Dosage regimens for and compositions including anti-rsv antibodies. 2020/0347120 A1).

Virus 52

Virus Clinical Trials Trials Disease 52

The Pharma Data

OCTOBER 31, 2020

Since the first cases were reported in March 2020 , there have been 234,511 cases of COVID-19, including 10,136 deaths reported in Canada ; these cumulative numbers tell us about the overall burden of COVID-19 illness to date. OTTAWA, ON , Nov. The number of people experiencing severe illness continues to increase.

Assisted Living 40

Assisted Living Hospitals Disease Laboratories 40

The Pharma Data

DECEMBER 7, 2020

7, 2020 — Scientists say they may be getting closer to creating a universal flu vaccine. In an early-stage clinical trial with 65 volunteers in the United States, an experimental vaccine triggered strong immune responses to a wide range of flu virus strains and subtypes. © 2020 HealthDay. Posted: December 2020.

Vaccine 52

Vaccine Immune Response Virus Clinical Trials 52

Agency IQ

MARCH 7, 2024

BY AMANDA CONTI | MAR 6, 2024 8:46 PM CST AgencyIQ’s quick primer on the influenza virus and how annual vaccine strains are selected Influenza viruses have caused untold illness and death through human history. A key part of the influenza virus’ ability to infect humans is hemagglutinin (HA), a glycoprotein found on the surface of the virus.

Vaccine 40

Vaccine FDA Virus Licensing 40

The Pharma Data

OCTOBER 20, 2020

20, 2020 — British scientists are infecting healthy volunteers with COVID-19, in hopes of speeding up vaccine development, TheWashington Post reported Tuesday. Between 50 and 90 healthy young adults will be given a lab-grown strain of the live virus while quarantined. © 2020 HealthDay. Posted: October 2020.

Trials 52

Trials Vaccine Virus Pharmaceutical Companies 52